Several peptides can increase testosterone, but they work through different mechanisms and not all of them raise testosterone directly. The peptides with the strongest evidence for boosting testosterone are kisspeptin-10, gonadorelin, and human chorionic gonadotropin (HCG). These work by stimulating your body’s own hormonal signaling chain rather than introducing synthetic testosterone from outside. Other peptides sometimes marketed for testosterone optimization, like growth hormone secretagogues or PT-141, have little or no direct effect on testosterone levels.
How Peptides Raise Testosterone
Your body produces testosterone through a signaling chain that starts in the brain. The hypothalamus releases a hormone called GnRH, which tells the pituitary gland to release LH (luteinizing hormone). LH then travels to the testes and signals cells there to produce testosterone. Peptides that increase testosterone work by activating one or more steps in this chain, essentially turning up the volume on your body’s existing system rather than bypassing it.
This distinction matters. Because these peptides work through your natural hormonal pathway, the testes stay active and continue producing testosterone on their own. That’s fundamentally different from injecting testosterone directly, which can shut down the signaling chain and cause the testes to shrink over time.
Kisspeptin-10
Kisspeptin-10 is the peptide with the most dramatic effect on testosterone in clinical studies. It works at the very top of the hormonal chain, acting on the hypothalamus to trigger GnRH release. In a clinical trial published in The Journal of Clinical Endocrinology and Metabolism, a continuous infusion of kisspeptin-10 nearly quadrupled LH levels (from 5.4 to 20.8 IU/liter) and raised testosterone from 16.6 to 24.0 nmol/liter, roughly a 45% increase.
Kisspeptin-10 also increases the pulse frequency of LH release, which matters because the testes respond best to rhythmic, pulsing signals rather than a steady stream. In trial participants, LH pulse frequency rose from about 0.7 to 1.0 pulses per hour during infusion. Researchers have also tested kisspeptin-10 in men with type 2 diabetes who had mildly low testosterone. A single intravenous dose more than doubled LH levels in both healthy men and diabetic men, and a longer infusion raised testosterone by about 34% in the diabetic group (from 8.5 to 11.4 nmol/liter).
Kisspeptin-10 is still primarily a research compound. It’s not widely available through standard clinical channels, and most of the human data comes from controlled infusion studies rather than the kind of self-administered injection protocols common in peptide therapy clinics.
Gonadorelin
Gonadorelin is a synthetic version of GnRH, the hormone your hypothalamus naturally releases. It acts one step downstream from kisspeptin, directly stimulating the pituitary gland to release LH and FSH, which in turn drive testosterone production and sperm development. It has become a popular option in men’s health clinics, particularly for men on testosterone replacement therapy who want to preserve fertility and prevent testicular atrophy.
In a study comparing pulsatile GnRH therapy to HCG-based therapy in men with hormonal deficiencies, both approaches successfully restored sperm production at similar rates (82% vs. 76%). But the GnRH approach worked faster, averaging about 12 months compared to nearly 15 months for HCG. Men on GnRH therapy also had larger testicular volume at the end of treatment (15 mL vs. 12 mL), suggesting better overall testicular health. The GnRH group also experienced fewer side effects: no significant issues were reported, while some men on HCG developed mild breast tissue growth.
The key to gonadorelin is pulsatile dosing. Your body naturally releases GnRH in pulses, and the pituitary gland responds best to that pattern. Continuous, nonstop stimulation can actually desensitize the pituitary and suppress LH over time, which is the opposite of the intended effect. This is why some clinics prescribe gonadorelin as multiple small injections throughout the day or use pump devices.
HCG (Human Chorionic Gonadotropin)
HCG is technically not a peptide in the same category as the others on this list, but it comes up in nearly every conversation about peptide-based testosterone support. It mimics LH, binding directly to the same receptors on testicular cells and stimulating testosterone production. For years, it was the standard add-on for men using testosterone replacement therapy who wanted to keep their testes functioning.
HCG works reliably, but it has some drawbacks compared to GnRH-based approaches. Because it stimulates the testes directly and bypasses the brain’s regulatory feedback, it can push sex hormone levels above normal physiological ranges. This overstimulation of testicular cells can lead to side effects like acne and breast tissue growth. HCG’s regulatory status has also shifted in recent years, making it harder to obtain from compounding pharmacies in some cases, which has driven more clinics toward gonadorelin as an alternative.
Growth Hormone Peptides and Testosterone
Peptides like CJC-1295, ipamorelin, and tesamorelin are growth hormone secretagogues, meaning they stimulate your pituitary gland to release more growth hormone. They’re often marketed alongside testosterone-boosting peptides, but their direct effect on testosterone is minimal. Tesamorelin, for instance, raises IGF-1 (a growth factor produced in the liver) and is FDA-approved for reducing abdominal fat in certain populations, but clinical data does not show it meaningfully increasing testosterone.
That said, growth hormone and testosterone do interact indirectly. Better body composition, less visceral fat, and improved sleep quality (all potential benefits of growth hormone peptides) can create conditions that support healthier testosterone levels over time. But if your primary goal is raising testosterone, these peptides aren’t the right tool for the job.
It’s also worth noting that the FDA has flagged several of these compounds for safety concerns. Ipamorelin is listed as a category 2 bulk drug substance, meaning the FDA considers it potentially risky for compounding, citing serious adverse events including death when administered intravenously. CJC-1295 has been associated with increased heart rate and blood vessel reactions. These peptides lack the kind of robust safety data that established pharmaceuticals require.
PT-141 (Bremelanotide)
PT-141 is another peptide frequently mentioned in the same breath as testosterone boosters, but it doesn’t increase testosterone. It works on melanocortin receptors in the brain, which stimulate dopamine release in areas involved in sexual arousal. The result is improved sexual desire and function, but through a completely different pathway than testosterone. If low libido is your concern and your testosterone levels are actually normal, PT-141 addresses the symptom without changing your hormone levels. If your testosterone is genuinely low, PT-141 won’t fix the underlying issue.
How Peptide Protocols Typically Work
Most peptide protocols follow a cycling approach to prevent your receptors from becoming desensitized. A common structure is five days on with two days off, typically dosing Monday through Friday. Full cycles usually run 12 to 16 weeks, followed by four to eight weeks off before starting again.
Peptides that target testosterone specifically, like gonadorelin, are often used continuously rather than cycled, particularly when prescribed alongside testosterone replacement therapy. The goal in that context is ongoing preservation of testicular function, not a temporary boost. Kisspeptin-10, by contrast, is still used mainly in research settings and doesn’t have established clinical dosing protocols for general use.
Injectable peptides require reconstitution (mixing a freeze-dried powder with sterile water) and subcutaneous injection, typically in the abdominal fat. They need to be refrigerated after mixing and generally remain stable for a few weeks. If you’re considering peptide therapy, working with a clinic that monitors your bloodwork before, during, and after treatment is the only way to know whether the peptides are actually changing your hormone levels or just emptying your wallet.